In the updated report by Future Market Insights, The non surgical fat reduction market is set to rise at a CAGR of 5.60% through 2034. The market value is slated to increase from US$ 1700.5 million in 2024 to US$ 2932.3 million by 2034.
The importance of appearance mostly drives the growing demand for non surgical fat reduction. As more people worry about their looks and posture, the popularity of obesity management treatments is growing globally. This will boost the non surgical fat reduction market's global expansion.
| Attributes | Key Insights |
|---|---|
| Market Size in 2024 | US$ 1,700.5 million |
| Market Value in 2034 | US$ 2,932.3 million |
| Value-based CAGR from 2024 to 2034 | 5.60% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2019 to 2023, the non surgical fat reduction market experienced a CAGR of 10.3%. Non-invasive fat reduction reduces resistant fat in specific body areas using various methods, including radiofrequency, laser lipolysis, and cryolipolysis.
Increased obesity rates in established and emerging countries, growing awareness, increased disposable income, and lifestyle changes brought on by urbanization are some of the factors expected to boost market sales.
Non-invasive procedures are displacing invasive surgeries rapidly, and people are choosing aesthetic procedures like body contouring more often due to their low risk and increased social media visibility. This will raise the market's income for non surgical fat reduction.
Several well-known competitors in the industry are always creating cutting-edge products by utilizing cutting-edge methods, including laser lipolysis, radiofrequency, and light treatment. Numerous businesses have introduced non-invasive red light therapy devices to decrease body fat in the marketplace.
Projections indicate that the global non surgical fat reduction market is expected to experience a CAGR of 5.6% from 2024 to 2034.
| Historical CAGR (2019 to 2023) | 10.3% |
|---|---|
| Forecasted CAGR (2024 to 2034) | 5.6% |
Principal Consultant
This section will detail the nonsurgical fat reduction markets in key countries, including the United States, Germany, the United Kingdom, China, and India. The below section will emphasize the reasons that are pushing growth in each of the regions.
Forecast CAGRs from 2024 to 2034
| Countries | CAGR |
|---|---|
| The United States | 1.7% |
| The United Kingdom | 2.4% |
| China | 1.8% |
| Germany | 3.1% |
| France | 3.5% |
The United States' nonsurgical fat reduction market is witnessing steady growth. In the forecast period, demand for nonsurgical fat reduction in the United States will likely rise at 1.70% CAGR.
Multiple factors are boosting the growth of the United States nonsurgical fat reduction market. These include the rising demand for minimally invasive cosmetic procedures driven by a strong emphasis on physical appearance and body image consciousness in American culture.
The increasing prevalence of obesity in the United States remains the prompting factor for fat reduction solutions. Nonsurgical options provide accessible and less invasive alternatives for individuals looking to address excess fat deposits.
Germany is emerging as a highly remunerative pocket for nonsurgical fat reduction providers, and the trend will likely continue through 2034. As per the latest analysis, demand for nonsurgical fat reduction in Germany is set to surge at 3.10% CAGR from 2024 to 2034.
This can be attributed to the rapidly growing healthcare sector and continuous innovation in cryolipolysis, laser therapy, radiofrequency, and ultrasound to improve treatment outcomes.
Many technical developments, like body contouring with cool sculpting, are expected to fuel the non surgical fat reduction market's growth. Germany is widely regarded as the global leader in reconstructive surgery, with a medical industry that integrates cutting-edge methods into its treatment protocols.
The nonsurgical fat reduction market in the United Kingdom expands at a CAGR of 2.40% throughout the forecast period. The rise is explained by the fact that cosmetic procedures have become much more common as the value of appearances has increased. The growth of cosmetic surgeons in the area contributes to the region's expansion.
As many prioritize maintaining a healthy lifestyle and aesthetic appearance, increasing focus on health and wellness contributes to the demand for nonsurgical fat reduction procedures.
Another key factor expected to propel nonsurgical fat reduction demand in the United Kingdom is the increasing awareness of health risks associated with excess body fat.
China’s nonsurgical fat reduction market is poised to exhibit a CAGR of 1.80% during the assessment period. This can be attributed to factors like the growing middle class and increasing disposable income levels have increased demand for aesthetic procedures, including non surgical fat-reduction treatments.
Shifting beauty ideas in China towards more Westernized aesthetics and increasing exposure to beauty trends through media and social media platforms have fuelled the interest in nonsurgical fat reduction procedures.
Rapid urbanization and modernization in China have led to a sedentary lifestyle and changes in dietary habits, contributing to a higher obesity rate and a desire for fat-reduction solutions.
Innovation and technology have been heavily invested in the Chinese healthcare sector, which has resulted in the creation of sophisticated non surgical fat reduction tools and methods. These developments fuel market growth, enhancing patient happiness, safety, and therapeutic efficacy.
As per the latest analysis, demand for nonsurgical fat reduction in France is set to surge at 3.50% CAGR from 2024 to 2034. The market demand is set to increase as consumers prioritize health, wellness, and physical appearance.
Personal style and attractiveness are highly valued in French society. Non surgical fat reduction methods are becoming increasingly popular among those looking to improve their appearance since they fit with the goal of a more youthful and slimmer silhouette.
Media attention and celebrity endorsements greatly influence French fashion and beauty standards. The public's acceptance and adoption of non surgical fat reduction procedures is facilitated by the media's positive representation of these treatments.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below section shows the leading segment. The cryolipolysis segment is to account for a market share of 33.50% in 2024. Based on end-users, the hospital segment is expected to have a share of 53.60%.
| Category | Market Share |
|---|---|
| Cryolipolysis | 33.50% |
| Hospitals | 53.60% |
Cryolipolysis Segment to account for a market share of 33.50% in 2024. Due to its effectiveness, rising safety, and low risk of adverse effects during and after the operation, cryolipolysis remains popular in the market in 2024.
A non-invasive therapy called cryolipolysis uses freezing temperatures to eliminate fat in the targeted location. The body's metabolic pathways subsequently eliminate the fat over two to six months.
Based on end-use, hospitals dominated the market in 2024 because they had access to a wide range of expensive fat-reduction equipment that used cutting-edge technology well. Hospital segment to account for market share of 53.60% in 2024.
The primary cause of this noteworthy expansion is the rise in people being admitted to hospitals for cosmetic operations. The integration of cutting-edge technology, sophisticated infrastructure, a variety of treatment options, and procedural skills will all contribute to an increase in patients in the upcoming years.
The non surgical fat reduction production area has multiple rivals, resulting in a highly fragmented industry overall. These businesses use strategies, including partnerships and collaborations, mergers and acquisitions, and new product releases, to meet consumer demand and grow their client base.
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 1,700.5 million |
| Projected Market Valuation in 2034 | US$ 2,932.3 million |
| Value-based CAGR 2024 to 2034 | 5.60% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ million |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
As of 2024, the market for non surgical fat reduction is expected to be valued at US$ 1700.5 million.
By 2034, the non surgical fat reduction market value is expected to reach US$ 2932.3 million.
From 2024 to 2034, the non surgical fat reduction market is expected to flourish at a CAGR of 5.60%
The Cryolipolysis segment is expected to account for a market share of 33.50% in 2024.
Germany is likely the top-performing market, with a CAGR of 3.10%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technique
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Technique, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technique, 2024 to 2034
5.3.1. Cryolipolysis
5.3.2. Ultrasound
5.3.3. Low-Level Lasers
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Technique, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Technique, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
6.3.1. Hospitals
6.3.2. Plastic Surgery Centres
6.3.3. Cosmetic and Aesthetic Clinics
6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Technique
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Technique
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Technique
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Technique
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Technique
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Technique
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Technique
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Technique
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Technique
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Technique
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Technique
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Technique
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Technique
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Technique
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2023
15.1.2.1. By Technique
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2023
15.2.2.1. By Technique
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2023
15.3.2.1. By Technique
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2023
15.4.2.1. By Technique
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2023
15.5.2.1. By Technique
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2023
15.6.2.1. By Technique
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2023
15.7.2.1. By Technique
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2023
15.8.2.1. By Technique
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2023
15.9.2.1. By Technique
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2023
15.10.2.1. By Technique
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2023
15.11.2.1. By Technique
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2023
15.12.2.1. By Technique
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2023
15.13.2.1. By Technique
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2023
15.14.2.1. By Technique
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2023
15.15.2.1. By Technique
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2023
15.16.2.1. By Technique
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2023
15.17.2.1. By Technique
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2023
15.18.2.1. By Technique
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2023
15.19.2.1. By Technique
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2023
15.20.2.1. By Technique
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2023
15.21.2.1. By Technique
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2023
15.22.2.1. By Technique
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2023
15.23.2.1. By Technique
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Technique
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Valeant Pharmaceuticals International, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Allergan plc
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Alma Lasers
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Cynosure, Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Sciton, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Solta Medical Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Lumenis Ltd.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Syneron Medical Ltd.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Lutronic Corporation
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Lynton Lasers Ltd.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Cutera Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Non Surgical Fat Reduction Market
